Characteristics of children readmitted with severe pneumonia in Kenyan hospitals.

Diana Marangu-Boore, Paul Mwaniki, Lynda Isaaka, Teresiah Njoroge, Livingstone Mumelo, Dennis Kimego, Achieng Adem, Elizabeth Jowi, Angeline Ithondeka, Conrad Wanyama, Ambrose Agweyu
Author Information
  1. Diana Marangu-Boore: Paediatric Pulmonology Division, Department of Paediatrics and Child Health, University of Nairobi, Nairobi, Kenya. dmarangu@uonbi.ac.ke.
  2. Paul Mwaniki: Epidemiology and Demography Department, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.
  3. Lynda Isaaka: Epidemiology and Demography Department, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.
  4. Teresiah Njoroge: Epidemiology and Demography Department, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.
  5. Livingstone Mumelo: Epidemiology and Demography Department, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.
  6. Dennis Kimego: Epidemiology and Demography Department, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.
  7. Achieng Adem: Department of Health, Kisumu County, Kenya.
  8. Elizabeth Jowi: Department of Health, Nairobi County, Kenya.
  9. Angeline Ithondeka: Department of Health, Nakuru County, Kenya.
  10. Conrad Wanyama: Epidemiology and Demography Department, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.
  11. Ambrose Agweyu: Epidemiology and Demography Department, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.

Abstract

BACKGROUND: Pneumonia is a leading cause of childhood morbidity and mortality. Hospital re-admission may signify missed opportunities for care or undiagnosed comorbidities.
METHODS: We conducted a retrospective cohort study including children aged 2 months-14 years hospitalised with severe pneumonia between 2013 and 2021 in a network of 20 primary referral hospitals in Kenya. Severe pneumonia was defined using the 2013 World Health Organization criteria, and re-admission was based on clinical documentation from individual patient case notes. We estimated the prevalence of re-admission, described clinical management practices, and modelled risk factors for re-admission and inpatient mortality.
RESULTS: Among 20,603 children diagnosed with severe pneumonia, 2,274 (11.0%, 95% CI 10.6-11.5) were readmitted. Re-admission was independently associated with age (12-59 months vs. 2-11 months: adjusted odds ratio (aOR) 1.70, 1.54-1.87; >5 years vs. 2-11 months: aOR 1.85, 1.55-2.22), malnutrition (weight-for-age-z-score (WAZ) <-3SD vs. WAZ> -2SD: aOR 2.05, 1.84-2.29); WAZ -���2 to -3 SD vs. WAZ> -2SD: aOR 1.37, 1.20-1.57), wheeze (aOR 1.17, 1.03-1.33) and presence of a concurrent neurological disorder (aOR 4.42, 1.70-11.48). Chest radiography was ordered more frequently among those readmitted (540/2,274 [23.7%] vs. 3,102/18,329 [16.9%], p���<���0.001). Readmitted patients more frequently received second-line antibiotics (808/2,256 [35.8%] vs. 5,538/18,173 [30.5%], p���<���0.001), TB medication (69/2,256 [3.1%] vs. 298/18,173 [1.6%], p���<���0.001), salbutamol (530/2,256 [23.5%] vs. 3,707/18,173 [20.4%], p���=���0.003), and prednisolone (157/2,256 [7.0%] vs. 764/18,173 [4.2%], p���<���0.001). Inpatient mortality was 2,354/18,329 (12.8%) among children admitted with a first episode of severe pneumonia and 269/2,274 (11.8%) among those who were readmitted (adjusted hazard ratio (aHR) 0.93, 95% CI 0.82-1.07). Age (12-59 months vs. 2-11 months: aHR 0.62, 0.57-0.67), male sex (aHR 0.81, 0.75-0.88), malnutrition (WAZ <-3SD vs. WAZ >-2SD: aHR 1.87, 1.71-2.05); WAZ -���2 to -3 SD vs. WAZ >-2SD: aHR 1.46, 1.31-1.63), complete vaccination (aHR 0.74, 0.60-0.91), wheeze (aHR 0.87, 0.78-0.98) and anaemia (aHR 2.14, 1.89-2.43) were independently associated with mortality.
CONCLUSIONS: Children readmitted with severe pneumonia account for a substantial proportion of pneumonia hospitalisations and deaths. Further research is required to develop evidence-based approaches to screening, case management, and follow-up of children with severe pneumonia, prioritising those with underlying risk factors for readmission and mortality.

Keywords

References

  1. BMC Health Serv Res. 2022 Dec 24;22(1):1579 [PMID: 36566173]
  2. Arch Dis Child. 2016 Mar;101(3):223-9 [PMID: 26662925]
  3. Stat Med. 2017 Sep 10;36(20):3257-3277 [PMID: 28543517]
  4. PLoS One. 2015 Jan 30;10(1):e0116380 [PMID: 25635911]
  5. Int J Methods Psychiatr Res. 2011 Mar;20(1):40-9 [PMID: 21499542]
  6. Int J Environ Res Public Health. 2020 Jun 27;17(13): [PMID: 32605136]
  7. BMJ. 2013 Dec 16;347:f7171 [PMID: 24342737]
  8. PLoS One. 2017 Aug 29;12(8):e0183860 [PMID: 28850581]
  9. Clin Genet. 2020 Mar;97(3):509-515 [PMID: 31650533]
  10. J Health Econ. 2013 Sep;32(5):909-21 [PMID: 23938273]
  11. BMJ Glob Health. 2021 Mar;6(3): [PMID: 33758014]
  12. Front Pediatr. 2022 Jul 25;10:954608 [PMID: 35958169]
  13. Pediatrics. 2017 Aug;140(2): [PMID: 28771422]
  14. Value Health Reg Issues. 2021 May;24:12-16 [PMID: 33465710]
  15. Am J Speech Lang Pathol. 2020 Jul 10;29(2S):1078-1093 [PMID: 32650657]
  16. Iran J Public Health. 2021 Jul;50(7):1372-1380 [PMID: 34568175]
  17. BMJ Open. 2021 Sep 7;11(9):e050995 [PMID: 34493522]
  18. Eur Respir Rev. 2023 Feb 21;32(167): [PMID: 36813289]
  19. Int J Clin Pract. 2021 Apr;75(4):e13695 [PMID: 32909345]
  20. Thorax. 2017 May;72(5):445-450 [PMID: 27856821]
  21. BMC Pulm Med. 2013 Oct 10;13:60 [PMID: 24106756]
  22. Arch Pediatr Adolesc Med. 2000 Feb;154(2):190-4 [PMID: 10665608]
  23. Multidiscip Respir Med. 2017 Apr 20;12:9 [PMID: 28435672]
  24. Int Stat Rev. 2017 Aug;85(2):185-203 [PMID: 29307954]
  25. Am J Respir Crit Care Med. 2017 Jan 15;195(2):212-220 [PMID: 27509359]
  26. Pediatrics. 2014 Jul;134(1):100-9 [PMID: 24958590]
  27. PLoS Med. 2007 Oct 16;4(10):e296 [PMID: 17941714]
  28. Int J Mol Sci. 2017 Jan 29;18(2): [PMID: 28146079]
  29. PLoS One. 2014 Sep 16;9(9):e107663 [PMID: 25225798]
  30. J Clin Epidemiol. 2019 Jun;110:63-73 [PMID: 30878639]
  31. Pediatrics. 2017 Aug;140(2): [PMID: 28771422]
  32. Front Pediatr. 2022 Apr 01;10:849105 [PMID: 35433543]
  33. S Afr Med J. 2018 Jul 25;108(8):624-628 [PMID: 30182874]
  34. Eur Respir J. 2019 Jul 11;54(1): [PMID: 30956212]
  35. J Pediatr Gastroenterol Nutr. 2021 Mar 1;72(3):372-377 [PMID: 33264182]
  36. Respirology. 2019 Nov;24(11):1053-1062 [PMID: 30801930]
  37. Ann Am Thorac Soc. 2017 Apr;14(4):500-504 [PMID: 28125277]
  38. S Afr Med J. 2019 Sep 10;109(8b):3-11 [PMID: 31662142]
  39. PLoS Med. 2019 Dec 31;16(12):e1002987 [PMID: 31891572]
  40. Semin Respir Infect. 1993 Mar;8(1):46-58 [PMID: 8372275]
  41. Pediatr Pulmonol. 2018 Sep;53(9):1179-1192 [PMID: 29870146]
  42. PLoS Med. 2016 Apr 12;13(4):e1001991 [PMID: 27070913]
  43. BMJ Open. 2022 May 2;12(5):e058901 [PMID: 35501079]
  44. Eur Respir J. 2019 Jul 11;54(1): [PMID: 30956212]
  45. Lancet Glob Health. 2018 Oct;6(10):e1087-e1099 [PMID: 30223984]
  46. Lancet Glob Health. 2023 Nov;11(11):e1684-e1685 [PMID: 37793415]
  47. BMJ Glob Health. 2019 Sep 03;4(5):e001715 [PMID: 31544003]
  48. Lancet Glob Health. 2018 Jan;6(1):e74-e83 [PMID: 29241618]
  49. Emerg Infect Dis. 2013 Feb;19(2):223-9 [PMID: 23347702]
  50. BMC Pediatr. 2009 Feb 23;9:15 [PMID: 19236689]
  51. Lancet Glob Health. 2018 Oct;6(10):e1048-e1049 [PMID: 30223976]
  52. J Trop Pediatr. 2003 Aug;49(4):212-5 [PMID: 12929881]
  53. Ann Am Thorac Soc. 2016 Sep;13(9):1607-14 [PMID: 27299853]
  54. J Clin Med. 2022 Feb 23;11(5): [PMID: 35268277]
  55. Ann Am Thorac Soc. 2014 Sep;11(7):1091-100 [PMID: 25079245]
  56. Clin Chest Med. 2023 Sep;44(3):623-634 [PMID: 37517840]
  57. J Trop Pediatr. 2022 Jun 6;68(4): [PMID: 35727140]
  58. Paediatr Perinat Epidemiol. 2017 May;31(3):233-242 [PMID: 28317139]

Grants

  1. MR/R006083/1/Department of Health and Social Care ; Foreign, Commonwealth & Development Office; Medical Research Council; Wellcome Trust

MeSH Term

Humans
Kenya
Child, Preschool
Male
Infant
Female
Pneumonia
Retrospective Studies
Child
Patient Readmission
Adolescent
Risk Factors
Severity of Illness Index

Word Cloud

Created with Highcharts 10.0.01vspneumonia0aHRsevereaORWAZmortalitychildren2readmittedre-admissionp���<���00012561732742-11months:87amongyears201320hospitalsclinicalcasemanagementriskfactors1195%CI5independentlyassociated12-59monthsadjustedratiomalnutrition<-3SDWAZ>-2SD:05-���2-3SDwheezefrequently[2333295%]8%>-2SD:BACKGROUND:PneumonialeadingcausechildhoodmorbidityHospitalmaysignifymissedopportunitiescareundiagnosedcomorbiditiesMETHODS:conductedretrospectivecohortstudyincludingagedmonths-14hospitalised2021networkprimaryreferralKenyaSeveredefinedusingWorldHealthOrganizationcriteriabaseddocumentationindividualpatientnotesestimatedprevalencedescribedpracticesmodelledinpatientRESULTS:Among603diagnosed0%106-11Re-admissionageodds7054-1>58555-222weight-for-age-z-score84-2293720-1571703-133presenceconcurrentneurologicaldisorder44270-1148Chestradiographyordered540/27%]102/18[169%]Readmittedpatientsreceivedsecond-lineantibiotics808/2[358%]538/18[30TBmedication69/2[31%]298/18[16%]salbutamol530/2707/18[204%]p���=���0003prednisolone157/2[70%]764/18[42%]Inpatient354/1812admittedfirstepisode269/2hazard9382-107Age6257-067malesex8175-08871-24631-163completevaccination7460-09178-098anaemia1489-243CONCLUSIONS:Childrenaccountsubstantialproportionhospitalisationsdeathsresearchrequireddevelopevidence-basedapproachesscreeningfollow-upprioritisingunderlyingreadmissionCharacteristicsKenyanAdolescentsAfricaLow-and-middle-incomecountriesLowerrespiratorytractinfectionsPaediatricsPersistentRecurrent

Similar Articles

Cited By

No available data.